<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.ukri.org/api"><gtr:projectComposition><gtr:collaborations/><gtr:leadResearchOrganisation url="http://gtr.ukri.org:80/organisation/473E1EF9-3692-4CD0-9EAE-04B012F1E792"><gtr:id>473E1EF9-3692-4CD0-9EAE-04B012F1E792</gtr:id><gtr:name>Deltex Medical Limited</gtr:name><gtr:address><gtr:line1>TERMINUS ROAD , CHICHESTER</gtr:line1><gtr:city>WEST SUSSEX</gtr:city><gtr:postCode>PO19 8TX</gtr:postCode><gtr:region>South East</gtr:region></gtr:address><gtr:typeInd>P</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/473E1EF9-3692-4CD0-9EAE-04B012F1E792" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:type="gtr:organisationParticipantRole"><gtr:id>473E1EF9-3692-4CD0-9EAE-04B012F1E792</gtr:id><gtr:name>Deltex Medical Limited</gtr:name><gtr:address><gtr:line1>TERMINUS ROAD , CHICHESTER</gtr:line1><gtr:city>WEST SUSSEX</gtr:city><gtr:postCode>PO19 8TX</gtr:postCode><gtr:region>South East</gtr:region></gtr:address><gtr:roles><gtr:role><gtr:name>PARTICIPANT</gtr:name></gtr:role><gtr:role><gtr:name>LEAD_PARTICIPANT</gtr:name></gtr:role></gtr:roles><gtr:offerGrant>168505.0</gtr:offerGrant><gtr:projectCost>481442.0</gtr:projectCost></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.ukri.org:80/person/1FE18660-06B6-4E05-AD0E-B4A29A6CD533"><gtr:id>1FE18660-06B6-4E05-AD0E-B4A29A6CD533</gtr:id><gtr:firstName>Jonathan</gtr:firstName><gtr:surname>Shaw</gtr:surname><gtr:roles><gtr:role><gtr:name>PROJECT_MANAGER</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.ukri.org:80/projects?ref=720663"><gtr:id>8729A82A-EB7D-432E-A712-7469C5A58D2A</gtr:id><gtr:title>Development of a 4Mhz suprasternal Doppler probe for cardiac output measurement</gtr:title><gtr:status>Closed</gtr:status><gtr:grantCategory>GRD Proof of Market</gtr:grantCategory><gtr:grantReference>720663</gtr:grantReference><gtr:abstractText>The accurate measurement of Cardiac Output (CO), the volume of blood pumped/min, is
critical for clinicians to assess cardiovascular function &amp;amp; fluid status. Several invasive &amp;amp; non
invasive techniques are currently available to determine CO; however these possess
limitations with accuracy &amp;amp; suitability for use in all patient types. Deltex Medical (Deltex)
currently manufactures a leading technology to assess CO using a 4MHz ultrasound
Oesophageal Doppler Monitor (ODM). The technology is highly precise &amp;amp; has been widely
demonstrated to improve patient outcome. However the probe is placed into the oesophagus
which can initiate a ?gag reflex?. The oesophageal probe is therefore not well tolerated in
awake patients. To address this issue, Deltex aims to develop a non invasive CO measurement
system based on Doppler ultrasound that can be applied non-invasively at the suprasternal
notch. Such an approach has been adopted previously by both Deltex &amp;amp; a competitor
(USCOM) using a reusable probe, resulting in issues with product sterility &amp;amp; high capital
costs (see innovation question). Therefore, Deltex intends to develop the suprasternal
ultrasound technique using a disposable 4 MHz probe. This has the major added advantage of
being compatible with the company?s existing installed monitor base. The technology will
initially be targeted towards the Enhanced Recovery Programme used in surgery, &amp;amp; in
intensive care, where success will reduce the length of hospital stay &amp;amp; associated healthcare
costs, &amp;amp; then extend CO measurement for use in new departments (e.g. cardiology, A&amp;amp;E,
sports medicine, etc.). To date, Deltex has undertaken a pilot study to identify the optimal
Doppler frequency, anatomical targets &amp;amp; begin verification of technical parameters such as
head size &amp;amp; signal resolution. With the intended development of the pre-production prototype
&amp;amp; a clinical trial, Deltex expects accumulated sales of at least &amp;pound;10M over 5yrs.</gtr:abstractText><gtr:fund><gtr:end>2017-02-28</gtr:end><gtr:funder url="http://gtr.ukri.org:80/organisation/E18E2F0F-AC7D-4E02-9559-669F7C8FEC74"><gtr:id>E18E2F0F-AC7D-4E02-9559-669F7C8FEC74</gtr:id><gtr:name>Innovate UK</gtr:name></gtr:funder><gtr:start>2015-06-01</gtr:start><gtr:type>INCOME_ACTUAL</gtr:type><gtr:valuePounds>168505</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs/><gtr:disseminationOutputs/><gtr:exploitationOutputs/><gtr:furtherFundingOutputs/><gtr:impactSummaryOutputs/><gtr:intellectualPropertyOutputs/><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs/><gtr:productOutputs/><gtr:researchDatabaseAndModelOutputs/><gtr:researchMaterialOutputs/><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs/></gtr:output><gtr:publications/><gtr:identifiers><gtr:identifier type="RCUK">720663</gtr:identifier></gtr:identifiers><gtr:healthCategories/><gtr:researchActivities/><gtr:researchSubjects/><gtr:researchTopics><gtr:researchTopic><gtr:id>D05BC2E0-0345-4A3F-8C3F-775BC42A0819</gtr:id><gtr:text>Unclassified</gtr:text></gtr:researchTopic></gtr:researchTopics><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>